COMMUNIQUÉS West-GlobeNewswire

Amedisys-Availity Relationship Yields Faster Payor Authorizations
22/02/2018
BATON ROUGE, La., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Thanks to a new relationship with Availity, LLC (“Availity”), Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home health, hospice and personal care [...]
Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period
22/02/2018
- Subscription period expected to end on March 2, 2018 at 5:00 PM ET NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") , announced today that [...]
XORTX Therapeutics Appoints Dave Matthews CFO
22/02/2018
CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]
Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018
22/02/2018
- Revenue for 2017 increased by 35% to $141.2 million (36% at constant currency) - - GAAP EPS for 2017 more than doubled to $0.72, including a positive $0.24 impact of U.S. tax reform - - Spectrum outperforms on revenue [...]
Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis
22/02/2018
Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis Diagnosis is one of the most important issues affecting health, longevity and well-being for rare disease patients [...]
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
22/02/2018
XERMELO ® (telotristat ethyl) U.S. Net Sales Since March 2017 Launch Reach $15.1 Million Regulatory Filings for Sotagliflozin in Patients with Type 1 Diabetes Expected in First Quarter of 2018 THE WOODLANDS, Texas, Feb [...]
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2017 Earnings Release Date and Conference Call
22/02/2018
NASHVILLE, Tenn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release [...]
Natus Announces $30 Million Share Repurchase Program
22/02/2018
PLEASANTON, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) announced that its Board of Directors has authorized the repurchase of up to $30 million of the Company's common stock. [...]
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
22/02/2018
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of care REMEDY trial lead by prominent neurologist Dr. Bruce Campbell, its [...]
RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update
22/02/2018
Key Highlights: Top-line results from the Phase III study with RHB-104 for Crohn’s disease expected in mid-2018 Top-line results from the confirmatory Phase III study with TALICIA ® for H. pylori infection expected in [...]
LHC Group and Almost Family Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger
22/02/2018
LAFAYETTE, La. and LOUISVILLE, Ky., Feb. 22, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (“LHC Group”) (NASDAQ: LHCG ) and Almost Family, Inc. (“Almost Family”) (NASDAQ: AFAM ) announced today that the waiting period under [...]
Loxo Oncology to Announce Fourth Quarter and Year-End 2017 Financial Results
22/02/2018
STAMFORD, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]
Achillion Announces Restructuring to Advance Corporate Strategy; Announces 2017 Fourth Quarter and Full Year Financial Results
22/02/2018
Corporate restructuring expected to enable Achillion to focus on goal of advancing its clinical and late-stage preclinical portfolio while maintaining a strong balance sheet Joseph Truitt, Chief Operating Officer, [...]
Biohit GastroPanel® test helps reducing unnecessary gastroscopies in pre-operative evaluation of the patients referred for bariatric surgery
22/02/2018
Biohit Oyj Press release, 22nd February, 2018 at 1:00 p.m. local time (EET) Bariatric (obesity) surgery has become increasingly common in Western countries as the ultimate means to reduce the excess weight in patients [...]
Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems
22/02/2018
LONDON, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the treatment of chronic diseases [...]
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide
22/02/2018
Bagsværd, Denmark, 22 February 2018 - Novo Nordisk today announced the headline results from PIONEER 1, the first phase 3a trial with oral semaglutide for treatment of adults with type 2 diabetes. Oral semaglutide is a [...]
Corline Biomedical AB: Publicerar bokslutskommuniké för 2017
22/02/2018
Corline Biomedical AB ("Corline") publicerar härmed bokslutskommuniké för räkenskapsåret 2017. Nedan följer en kort sammanfattning. Fullständig bokslutskommuniké finns tillgänglig på Corlines hemsida ( www.corline.se ) [...]
LIDDS presenterar bokslutskommuniké 2017
22/02/2018
BOKSLUTSKOMMUNIKÉ 2017 FJÄRDE KVARTALET - OKTOBER - DECEMBER 2017 Nettoomsättningen uppgick till 0,4 (0,0) KSEK Kostnaderna uppgick till 2,5 (2,1) MSEK Resultatet före och efter skatt uppgick till -2,2 (-2,1) MSEK [...]
Ossur Hf : Final agenda and proposals for the Annual General Meeting 8 March 2018
22/02/2018
Announcement no. 12/2018 Reykjavik, 22 February 2018 Final agenda and proposals Enclosed is the final agenda and proposals for Össur's Annual General Meeting, to be held on Thursday 8 March 2018. The meeting will be [...]

Pages